Slow-k and Desyrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Slow-k (potassium chloride) and Desyrel (trazodone hydrochloride). Common drug interactions include application site pruritus among females and rhabdomyolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Slow-k and Desyrel. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Slow-k?

Slow-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 3,683 Slow-k users. Check the latest studies of Slow-k.

What is Desyrel?

Desyrel has active ingredients of trazodone hydrochloride. It is often used in insomnia. eHealthMe is studying from 6,595 Desyrel users. Check the latest studies of Desyrel.

On Jul, 09, 2026

16 people who take Slow-k and Desyrel together, and have interactions are studied.

What are the common drug interactions of Slow-K and Desyrel, by gender? *:

female:

Application site pruritus (application site severe itching of the skin)
Drug administration error
Loss of consciousness
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

male:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Abscess neck (neck abscesses)
Weight increased
Infusion site infection
Infusion site induration
Bowel movement irregularity
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Electrocardiogram qt prolonged
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations)

What are the common drug interactions of Slow-K and Desyrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abscess neck (neck abscesses)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site inflammation
Infusion site pain
Infusion site swelling
Infusion site warmth
Renal impairment (severely reduced kidney function)
Weight increased
Infusion site infection
Infusion site induration

40-49:

Loss of consciousness

50-59:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

60+:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Application site pruritus (application site severe itching of the skin)
Suicidal ideation
Bowel movement irregularity
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Drug administration error
Electrocardiogram qt prolonged
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations)

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 31.25%
Injection Site Pain: 4 people, 25.00%
High Blood Pressure: 3 people, 18.75%
Pain: 2 people, 12.50%
Gastritis (inflammation of stomach): 2 people, 12.50%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 6.25%
Constipation: 1 person, 6.25%
Fever: 1 person, 6.25%
Gastric Ulcer (stomach ulcer): 1 person, 6.25%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Slow-k and Desyrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously